A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors - PubMed (original) (raw)
. 2006 Mar 24;124(6):1169-81.
doi: 10.1016/j.cell.2006.02.037.
Carlos le Sage, Mariette Schrier, Ad J M Gillis, Hans Stoop, Remco Nagel, Ying-Poi Liu, Josyanne van Duijse, Jarno Drost, Alexander Griekspoor, Eitan Zlotorynski, Norikazu Yabuta, Gabriella De Vita, Hiroshi Nojima, Leendert H J Looijenga, Reuven Agami
Affiliations
- PMID: 16564011
- DOI: 10.1016/j.cell.2006.02.037
Free article
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors
P Mathijs Voorhoeve et al. Cell. 2006.
Free article
Abstract
Endogenous small RNAs (miRNAs) regulate gene expression by mechanisms conserved across metazoans. While the number of verified human miRNAs is still expanding, only few have been functionally annotated. To perform genetic screens for novel functions of miRNAs, we developed a library of vectors expressing the majority of cloned human miRNAs and created corresponding DNA barcode arrays. In a screen for miRNAs that cooperate with oncogenes in cellular transformation, we identified miR-372 and miR-373, each permitting proliferation and tumorigenesis of primary human cells that harbor both oncogenic RAS and active wild-type p53. These miRNAs neutralize p53-mediated CDK inhibition, possibly through direct inhibition of the expression of the tumor-suppressor LATS2. We provide evidence that these miRNAs are potential novel oncogenes participating in the development of human testicular germ cell tumors by numbing the p53 pathway, thus allowing tumorigenic growth in the presence of wild-type p53.
Similar articles
- A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.
Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A, Zlotorynski E, Yabuta N, De Vita G, Nojima H, Looijenga LH, Agami R. Voorhoeve PM, et al. Adv Exp Med Biol. 2007;604:17-46. doi: 10.1007/978-0-387-69116-9_2. Adv Exp Med Biol. 2007. PMID: 17695719 - Relevance of microRNAs in normal and malignant development, including human testicular germ cell tumours.
Looijenga LH, Gillis AJ, Stoop H, Hersmus R, Oosterhuis JW. Looijenga LH, et al. Int J Androl. 2007 Aug;30(4):304-14; discussion 314-5. doi: 10.1111/j.1365-2605.2007.00765.x. Epub 2007 Jun 15. Int J Androl. 2007. PMID: 17573854 - MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY. Corney DC, et al. Cancer Res. 2007 Sep 15;67(18):8433-8. doi: 10.1158/0008-5472.CAN-07-1585. Epub 2007 Sep 6. Cancer Res. 2007. PMID: 17823410 - MicroRNAs: small but potent oncogenes or tumor suppressors.
Lee YS, Dutta A. Lee YS, et al. Curr Opin Investig Drugs. 2006 Jun;7(6):560-4. Curr Opin Investig Drugs. 2006. PMID: 16784027 Review. - Oncogenic role of microRNAs in brain tumors.
Pang JC, Kwok WK, Chen Z, Ng HK. Pang JC, et al. Acta Neuropathol. 2009 Jun;117(6):599-611. doi: 10.1007/s00401-009-0525-0. Epub 2009 Apr 3. Acta Neuropathol. 2009. PMID: 19343354 Review.
Cited by
- miR-205: A Potential Biomedicine for Cancer Therapy.
Chauhan N, Dhasmana A, Jaggi M, Chauhan SC, Yallapu MM. Chauhan N, et al. Cells. 2020 Aug 25;9(9):1957. doi: 10.3390/cells9091957. Cells. 2020. PMID: 32854238 Free PMC article. Review. - miRNAs in human cancer.
Zhong X, Coukos G, Zhang L. Zhong X, et al. Methods Mol Biol. 2012;822:295-306. doi: 10.1007/978-1-61779-427-8_21. Methods Mol Biol. 2012. PMID: 22144208 Free PMC article. - MicroRNAs as newer therapeutic targets: A big hope from a tiny player.
Ghelani HS, Rachchh MA, Gokani RH. Ghelani HS, et al. J Pharmacol Pharmacother. 2012 Jul;3(3):217-27. doi: 10.4103/0976-500X.99416. J Pharmacol Pharmacother. 2012. PMID: 23129956 Free PMC article. - miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1.
Cohen R, Greenberg E, Nemlich Y, Schachter J, Markel G. Cohen R, et al. Oncotarget. 2015 Aug 7;6(22):19006-16. doi: 10.18632/oncotarget.4147. Oncotarget. 2015. PMID: 26158900 Free PMC article. - Epigenetic alterations as therapeutic targets in Testicular Germ Cell Tumours : current and future application of 'epidrugs'.
Cardoso AR, Lobo J, Miranda-Gonçalves V, Henrique R, Jerónimo C. Cardoso AR, et al. Epigenetics. 2021 Apr;16(4):353-372. doi: 10.1080/15592294.2020.1805682. Epub 2020 Aug 12. Epigenetics. 2021. PMID: 32749176 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous